Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Completed × Methylene Blue × Clear all

Phase

Phase NA 8 Phase 2 2 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Shock, Septic 1

Interventions

Cisplatin 22 Fluorouracil 21 Radiotherapy 18 Gemcitabine 17 Docetaxel 16 Oxaliplatin 15 Paclitaxel 14 Carboplatin 13 Capecitabine 13 Bevacizumab 13 Leucovorin 11 Cyclophosphamide 11 Irinotecan 10 Drug Therapy 10 Cytarabine 9 Saline Solution 7 Magnetic Resonance Spectroscopy 7 Letrozole 7 Dexamethasone 7 pembrolizumab 6 Rituximab 6 Nivolumab 6 Methotrexate 6 Exercise 6 Etoposide 6 Electroporation 6 Doxorubicin 6 Pemetrexed 5 Melphalan 5 Lidocaine 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06005558 2024-07-05

Low Dose Versus High Dose Methylene Blue in Septic Patients

National Cancer Institute, Egypt

Phase 2/3 Completed

Shock, Septic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡